10.34500 EUR
0.01
0.10%
Last update Dec 17, 7:31 PM CET
Market closed
Day range
10.30000
10.67500
Previous close
10.35500
Open
10.31000
Access this stock data via API
Subscribe
Emergent BioSolutions Inc.
10.35
0.01
0.10%

Financials

Income statement

Fundamentals currency is USD
Fiscal date 2024 2023 2022 2021
Total reported revenue 863.8M 1.0B 1.1B 1.6B
Cost of revenue 580.6M 705.4M 693.1M 748.1M
Gross profit 283.2M 317.6M 383M 891.3M
Operating expense
Research & development 60.3M 111.4M 188.3M 235.2M
Selling general and admin 262.5M 368.4M 339.5M 348.7M
Other operating expenses -25.6M -26.3M -41.4M -134.2M
Operating income -69.5M -201.5M -163.3M 383.1M
Non operating interest income
Income
Expense 60.5M 87.9M 37.3M 34.5M
Other income expense 8.2M -441.8M -18.4M -45.4M
Pretax income -121.8M -731.2M -219M 303.2M
Tax provision 40.7M 29.3M -7.4M 83.7M
Net income -162.4M -760.5M -211.6M 219.5M
Basic EPS -3.6 -14.9 -4.5 4.3
Diluted EPS -3.6 -14.9 -4.5 4.3
Basic average shares 45.2M 54.4M 52.1M 55.7M
Diluted average shares 45.2M 54.4M 52.1M 55.7M
EBITDA 33.9M -67.5M -31.7M 503.2M
Net income from continuing op. -162.4M -760.5M -211.6M 219.5M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Main market opens in 11 hours

20:59
00:00
08:00
20:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 20:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).